CD274 and melanoma: While this pattern may seem to contrast with recent findings in melanoma—where succinylation of PD-L1 at lysine 129 was reported to promote its degradation and enhance antitumor immunity (23)—it is important to recognize that the immunological effects of succinylation are likely highly context- and cell type–dependent.